Strategic Financial Concepts’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.14M Buy
+50,995
New +$1.62M 0.64% 46
2025
Q4
Sell
-44,316
Closed -$1.23M 134
2025
Q3
$1.23M Buy
+44,316
New +$1.12M 0.18% 67

Other funds holding ARKG

Strategic Financial Concepts's ARKG Position: Q2 2026 in Review

Strategic Financial Concepts opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 50,995 shares worth $2.14M. The stake represents 0.64% of the portfolio and ranks #46 among its holdings. This is a return to the name: Strategic Financial Concepts previously reported a position in ARKG as recently as Q3 2025.

Strategic Financial Concepts first reported a position in ARKG in Q3 2025 and has held it in 2 quarters since. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Strategic Financial Concepts held 50,995 shares of ARK Genomic Revolution ETF worth $2.14M as of Q2 2026.
  • ARK Genomic Revolution ETF was a new Strategic Financial Concepts position in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.64% of Strategic Financial Concepts's portfolio in Q2 2026, its #46 holding.
  • Strategic Financial Concepts first reported a position in ARK Genomic Revolution ETF in Q3 2025 and has held it in 2 quarters since.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Strategic Financial Concepts's 13F filing for Q2 2026, filed 28 Jul 2026.